Mutation Screening of KRAS in FFPE samples using Pyrosequencing Phil Chambers CR-UK Genome Variation Laboratory Service St. James’s University Hospital.
Breaking news from IST-3 Peter Sandercock University of Edinburgh on behalf of the IST-3 collaborative group ESC London 29 th May 2013.
Neil H. Segal, M.D., Ph.D. Assistant Attending Gastrointestinal Oncology Service and Immunotherapeutics Core Memorial Sloan-Kettering Cancer Center.
Institute for Cancer Research and Treatment Candiolo (TURIN) - Italy Long-Term Data for 884 Patients Show Vertebroplasty for Osteoporotic Spinal Fractures.
Tom A. Elasy, M.D., M.P.H. Vanderbilt University February, 2012.
Infusional 5-FU/FA plus Oxaliplatin (FUFOX) vs. Capecitabine plus Oxaliplatin (CAPOX) as first-line treatment for metastatic colorectal cancer: safety.
Improving the standard of care for patients with hormone resistant prostate cancer Teresa Gamucci Sora-Frosinone Highlights in the Management of Urogenital.
Campus dev con at apc - Dustin Masangcay - Creating the Next PH growth story
ADHD in children with ADHD in children with neurological ...
Detailer fet brief (15 aug 2013)
GE's Two-Decade Transformation: Jack Welch's Leadership
Recent Advances In The Development Of Innovative Therapies The Celgene Pipeline
